Covered recipient · General Payments record
ORESTES MOLDES-RODRIGUEZ
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,419.01
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,294.02 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $960.62 | 26 |
| Madrigal Pharmaceuticals | $145.63 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $80.80 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.87 | 2 |
| Celgene Corporation | $20.15 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.16 | 1 |
| Medtronic, Inc. | $13.99 | 1 |
| Micro-tech Endoscopy USA, Inc. | $9.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $99.27 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053552 | CMS |
| ABBVIE INC. | $124.99 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053554 | CMS |
| ABBVIE INC. | $17.21 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053556 | CMS |
| ABBVIE INC. | $16.57 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053558 | CMS |
| ABBVIE INC. | $21.78 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053560 | CMS |
| ABBVIE INC. | $18.73 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053562 | CMS |
| ABBVIE INC. | $28.57 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053564 | CMS |
| ABBVIE INC. | $9.83 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053566 | CMS |
| ABBVIE INC. | $23.48 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053568 | CMS |
| ABBVIE INC. | $106.94 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053570 | CMS |
| ABBVIE INC. | $19.35 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053572 | CMS |
| ABBVIE INC. | $23.22 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053574 | CMS |
| ABBVIE INC. | $10.00 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053576 | CMS |
| ABBVIE INC. | $25.44 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053578 | CMS |
| ABBVIE INC. | $19.48 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053580 | CMS |
| ABBVIE INC. | $121.48 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053582 | CMS |
| ABBVIE INC. | $28.24 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053584 | CMS |
| ABBVIE INC. | $26.75 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053586 | CMS |
| ABBVIE INC. | $103.19 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053588 | CMS |
| ABBVIE INC. | $10.42 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053590 | CMS |
| ABBVIE INC. | $14.92 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053592 | CMS |
| ABBVIE INC. | $16.88 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053594 | CMS |
| ABBVIE INC. | $12.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053596 | CMS |
| ABBVIE INC. | $16.58 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053598 | CMS |
| ABBVIE INC. | $24.25 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053600 | CMS |
| ABBVIE INC. | $20.10 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053602 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $80.80 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146959525 | CMS |
| Celgene Corporation | $20.15 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101133050 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.16 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101418383 | CMS |
| Madrigal Pharmaceuticals | $145.63 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144176417 | CMS |
| Medtronic, Inc. | $13.99 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119499148 | CMS |
| Micro-tech Endoscopy USA, Inc. | $9.80 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1088809253 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.89 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137637390 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.98 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137637392 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.